apomorphine has been researched along with droperidol in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (57.14) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Di Chiara, G; Gessa, GL; Morelli, M; Porceddu, ML | 1 |
| Frussa-Filho, R; Palermo-Neto, J | 1 |
| Kuschinsky, K; Nowak, K; Welsch-Kunze, S | 1 |
| Artalejo, AR; Bermejo, PM; Montiel, C; Sánchez-García, P | 1 |
| Bannet, J; Belmaker, RH; Elami, A | 1 |
| Baldessarini, RJ; Campbell, A; Kula, NS; Teicher, MH | 1 |
| Boudier, HA; Cools, AR; Geilen, W; Van Rossum, JM | 1 |
| Gale, K | 1 |
| Booth, NH; Keith, JC; Kemppainen, RJ; Wilson, RC | 1 |
| Goncharenko, NV; Pankrat'ev, DV; Talalaenko, AN | 1 |
1 review(s) available for apomorphine and droperidol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
13 other study(ies) available for apomorphine and droperidol
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Self-inhibitory dopamine-receptors and central effects of apomorphine.
Topics: Animals; Apomorphine; Benperidol; Brain; Clozapine; Droperidol; Exploratory Behavior; Haloperidol; Humans; Mice; Motor Activity; Pimozide; Rats; Receptors, Dopamine; Sleep | 1978 |
Effects of single and long-term droperidol administration on open-field and stereotyped behavior of rats.
Topics: Animals; Apomorphine; Arousal; Brain; Droperidol; Long-Term Care; Male; Motor Activity; Motor Skills; Neural Pathways; Rats; Rats, Inbred Strains; Receptors, Dopamine; Social Environment; Stereotyped Behavior | 1991 |
Conditioned tolerance to haloperidol- and droperidol-induced catalepsy.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Brain; Catalepsy; Conditioning, Psychological; Dopamine; Droperidol; Drug Tolerance; Haloperidol; Male; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1988 |
A dopaminergic receptor in adrenal medulla as a possible site of action for the droperidol-evoked hypertensive response.
Topics: Adrenal Medulla; Animals; Apomorphine; Catecholamines; Cats; Depression, Chemical; Droperidol; Female; Humans; Hypertension; In Vitro Techniques; Male; Nicotine; Perfusion; Receptors, Dopamine; Receptors, Nicotinic | 1986 |
Intermittent treatment with droperidol, a short-acting neuroleptic, increases behavioral dopamine receptor sensitivity.
Topics: Animals; Apomorphine; Brain; Droperidol; Drug Administration Schedule; Humans; Rats; Receptors, Dopamine; Stereotyped Behavior | 1985 |
Prolonged antidopaminergic actions of single doses of butyrophenones in the rat.
Topics: Animals; Apomorphine; Butyrophenones; Dopamine Antagonists; Droperidol; Half-Life; Haloperidol; Male; Rats; Rats, Inbred Strains; Stereotyped Behavior; Time Factors | 1985 |
Pharmacological analysis of dopamine-induced inhibition and excitation of neurones of the snail Helix aspersa.
Topics: Animals; Apomorphine; Butyrophenones; Dopamine; Dopamine Antagonists; Droperidol; Epinephrine; Ergot Alkaloids; Haloperidol; In Vitro Techniques; Isoproterenol; Methyldopa; Neurons; Norepinephrine; Phenylephrine; Snails; Time Factors | 1974 |
Catecholamine-independent behavioral and neurochemical effects of cocaine in rats.
Topics: Animals; Apomorphine; Avoidance Learning; Behavior, Animal; Brain Chemistry; Catecholamines; Cocaine; Corpus Striatum; Droperidol; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Humans; Rats; Receptors, Dopamine; Receptors, GABA-A; Stereotyped Behavior; Taste; Time Factors | 1984 |
Failure of naloxone to prevent the emetic activity of apomorphine in dogs.
Topics: Animals; Apomorphine; Dogs; Droperidol; Female; Fentanyl; Haloperidol; Injections, Intravenous; Male; Naloxone; Time Factors; Vomiting | 1981 |
Neurochemical characteristics of the ventromedial hypothalamus in mediating the antiaversive effects of anxiolytics in different models of anxiety.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Anti-Anxiety Agents; Anticonvulsants; Anxiety; Apomorphine; Avoidance Learning; Biguanides; Brain Chemistry; Chlordiazepoxide; Clonidine; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Droperidol; Drug Interactions; GABA Agents; GABA Antagonists; GABA Modulators; gamma-Aminobutyric Acid; Glutamic Acid; Male; Memantine; Mephenytoin; Microinjections; Pentylenetetrazole; Phentolamine; Picrotoxin; Piperazines; Propranolol; Pyrimidines; Rats; Serotonin; Sulpiride; Ventromedial Hypothalamic Nucleus; Yohimbine | 2003 |